Dandan Shi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Dandan Shi has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Hua Liao
Department of Human Anatomy, School of Basic Medical Sciences Southern Medical University Guangzhou China
2 shared publications Rong Zhu
Department of Anatomy, Guangdong Provincial Key Laboratory of Construction and Detection in Tissue Engineering Southern Medical University Guangzhou, 510515 China
2 shared publicationsBiao Cao
Department of Anatomy, Guangdong Provincial Key Laboratory of Construction and Detection in Tissue Engineering, Southern Medical University, Guangzhou, 510515 China
1 shared publication- Gang Wu
School of Materials Science and Engineering South China University of Technology Guangzhou P. R. China
1 shared publication - HuiJun Zeng
Department of Neurosurgery Center, The National Key Clinical Specialty, The Engineering Technology Research Center of Education Ministry of China on Diagnosis and Treatment of Cerebrovascular Disease, Guangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, The Neurosurgery Institute of Guangdong Province, Zhujiang Hospital, Southern Medical University, Guangzhou, China
1 shared publication - JiJie Hu
Key Laboratory of High-Speed Railway Engineering of Ministry of Education, Southwest Jiaotong University, Chengdu, China
1 shared publication
Latest Publications
- 3 November 2024
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1879 (6) , 189207
Structure, function, signaling pathways and clinical therapeutics: The translational potential of STAT3 as a target for cancer therapy
- 3 November 2024
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1879 (6) , 189207
Structure, function, signaling pathways and clinical therapeutics: The translational potential of STAT3 as a target for cancer therapy
- Open Access
- 2 July 2018
- Published by Wiley in The Anatomical Record
- Vol. 301 (9) , 1551-1563
Immunological Behavior Analysis of Muscle Cells under IFN‐γ Stimulation in Vitro and in Vivo
Muscle cells could serve as antigen‐presenting cells, and participate in the activation of immune response. Immunological characteristics of muscle cells, and their capacities to equip themselves with immunorelevant molecules, remain to be elucidated. In this study, we investigated the immunological properties of myoblasts and differentiated myotubes in vitro and in vivo, under the IFN‐γ induced inflammatory condition. We found that the fused C2C12 myotubes are more sensitive to inflammatory stimulation, and significantly upregulated the expression levels of MHC‐I/II and TLR3/7 molecules, than that of proliferated myoblasts. As well, some co‐stimulatory/‐inhibitory molecules, including CD40, CD86, ICAM‐I, ICOS‐L, and PD‐L1, were prominently upregulated in IFN‐γ induced myotubes. Notably, we detected the protein levels of ASC, NLRP3, and Caspase‐1 increased in stimulated myotubes, and IL‐1β in cell culture supernatant, implying the activation of NLRP3 inflammasomes in IFN‐γ treated myotubes. The pro‐inflammatory cytokines and chemokines mRNA levels in IFN‐γ induced C2C12 myotubes and myoblasts, involving IL‐1, IL‐6, and MCP‐1, increased markedly. T cell activation test further verified IFN‐γ induced C2C12 myotubes prompt to the proliferation of the splenic CD4+ and CD8+ T cells. In Cardiotoxin‐damaged tibialis anterior (TA) muscle, some regenerated myofibers expressed both MHC class I and class II molecules under IFN‐γ enhanced inflammatory condition. Thus, our work demonstrates that muscle cells are active participants of local immune reactions. Anat Rec, 301:1551–1563, 2018.
- 2 July 2018
- Published by Wiley in The Anatomical Record
- Vol. 301 (9) , 1551-1563
Open AccessImmunological Behavior Analysis of Muscle Cells under IFN‐γ Stimulation in Vitro and in Vivo
Muscle cells could serve as antigen‐presenting cells, and participate in the activation of immune response. Immunological characteristics of muscle cells, and their capacities to equip themselves with immunorelevant molecules, remain to be elucidated. In this study, we investigated the immunological properties of myoblasts and differentiated myotubes in vitro and in vivo, under the IFN‐γ induced inflammatory condition. We found that the fused C2C12 myotubes are more sensitive to inflammatory stimulation, and significantly upregulated the expression levels of MHC‐I/II and TLR3/7 molecules, than that of proliferated myoblasts. As well, some co‐stimulatory/‐inhibitory molecules, including CD40, CD86, ICAM‐I, ICOS‐L, and PD‐L1, were prominently upregulated in IFN‐γ induced myotubes. Notably, we detected the protein levels of ASC, NLRP3, and Caspase‐1 increased in stimulated myotubes, and IL‐1β in cell culture supernatant, implying the activation of NLRP3 inflammasomes in IFN‐γ treated myotubes. The pro‐inflammatory cytokines and chemokines mRNA levels in IFN‐γ induced C2C12 myotubes and myoblasts, involving IL‐1, IL‐6, and MCP‐1, increased markedly. T cell activation test further verified IFN‐γ induced C2C12 myotubes prompt to the proliferation of the splenic CD4+ and CD8+ T cells. In Cardiotoxin‐damaged tibialis anterior (TA) muscle, some regenerated myofibers expressed both MHC class I and class II molecules under IFN‐γ enhanced inflammatory condition. Thus, our work demonstrates that muscle cells are active participants of local immune reactions. Anat Rec, 301:1551–1563, 2018.
- Open Access
- 1 January 2015
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 11 (2) , 156-167
Effects of Nitric Oxide on Notexin-Induced Muscle Inflammatory Responses
Excessive inflammatory response may delay the regeneration and damage the normal muscle fibers upon myoinjury. It would be important to be able to attenuate the inflammatory response and decrease inflammatory cells infiltration in order to improve muscle regeneration formation, resulting in better muscle functional recovery after myoinjury. This study was undertaken to explore the role of Nitric oxide (NO) during skeletal muscle inflammatory process, using a mouse model of Notexin induced myoinjury. Intramuscular injection (tibialis anterior, TA) of Notexin was performed for preparing mice myoinjury. NO synthase inhibitor (L-NAME) or NO donor (SNP) was intraperitoneally injected into model mice. On day 4 and 7 post-injury, expression of muscle-autoantigens and toll-like receptors (TLRs) was evaluated from muscle tissue by qRT-PCR and Western Blot; the intramuscular infiltration of monocytes/macrophage (CD11b+ or F4/80+ cells), CD8+ T cell (CD3ε+CD8α+), apoptotic cell (CD11b+caspase3+), and MHC-I molecule H-2Kb-expressing myofibers in damaged muscle were assessed by imunoflourecence analysis; the mRNAs expression of cytokines and chemokines associated with the preferential biological role during the muscle damage-induced inflammation response, were assessed by qRT-PCR. We detected the reduced monocytes/macrophages infiltration, and increased apoptotic cells in the damaged muscle treated with SNP comparing to untreatment. As well, SNP treatment down-regulated mRNA and protein levels of muscle autoantigens, TLR3, and mRNA levels of TNF-α, IL-6, MCP-1, MCP-3, and MIP-1α in damaged muscle. On the contrary, L-NAME induced more severe intramuscular infiltration of inflammatory cells, and mRNA level elevation of the above inflammatory mediators. Notably, we observed an increased number of MHC-I (H2-Kb) positive new myofibers, and of the infiltrated CD8+ T cells in damaged muscle at the day 7 after L-NAME treatment. The result herein shows that, NO can act as an endogenous anti-inflammatory molecule during the ongoing muscle inflammation. Our finding may provide new insight to optimize NO-based therapies for improving muscle regeneration after myoinjury.
- 1 January 2015
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 11 (2) , 156-167
Open AccessEffects of Nitric Oxide on Notexin-Induced Muscle Inflammatory Responses
Excessive inflammatory response may delay the regeneration and damage the normal muscle fibers upon myoinjury. It would be important to be able to attenuate the inflammatory response and decrease inflammatory cells infiltration in order to improve muscle regeneration formation, resulting in better muscle functional recovery after myoinjury. This study was undertaken to explore the role of Nitric oxide (NO) during skeletal muscle inflammatory process, using a mouse model of Notexin induced myoinjury. Intramuscular injection (tibialis anterior, TA) of Notexin was performed for preparing mice myoinjury. NO synthase inhibitor (L-NAME) or NO donor (SNP) was intraperitoneally injected into model mice. On day 4 and 7 post-injury, expression of muscle-autoantigens and toll-like receptors (TLRs) was evaluated from muscle tissue by qRT-PCR and Western Blot; the intramuscular infiltration of monocytes/macrophage (CD11b+ or F4/80+ cells), CD8+ T cell (CD3ε+CD8α+), apoptotic cell (CD11b+caspase3+), and MHC-I molecule H-2Kb-expressing myofibers in damaged muscle were assessed by imunoflourecence analysis; the mRNAs expression of cytokines and chemokines associated with the preferential biological role during the muscle damage-induced inflammation response, were assessed by qRT-PCR. We detected the reduced monocytes/macrophages infiltration, and increased apoptotic cells in the damaged muscle treated with SNP comparing to untreatment. As well, SNP treatment down-regulated mRNA and protein levels of muscle autoantigens, TLR3, and mRNA levels of TNF-α, IL-6, MCP-1, MCP-3, and MIP-1α in damaged muscle. On the contrary, L-NAME induced more severe intramuscular infiltration of inflammatory cells, and mRNA level elevation of the above inflammatory mediators. Notably, we observed an increased number of MHC-I (H2-Kb) positive new myofibers, and of the infiltrated CD8+ T cells in damaged muscle at the day 7 after L-NAME treatment. The result herein shows that, NO can act as an endogenous anti-inflammatory molecule during the ongoing muscle inflammation. Our finding may provide new insight to optimize NO-based therapies for improving muscle regeneration after myoinjury.